Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 2Wilms Tumor 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, AIDS-Related 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Monocytic, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Hepatoblastoma 1Carcinoma, Renal Cell 1

Interventions

Cytarabine 23Mitoxantrone 9Etoposide 8Idarubicin 5Filgrastim 5tipifarnib 4fludarabine phosphate 4Daunorubicin 4Cyclophosphamide 4Topotecan 3Sorafenib 3Clofarabine 3Bortezomib 3Azacitidine 3tanespimycin 2alvocidib 2Peripheral Blood Stem Cell Transplantation 2Imatinib Mesylate 2Granulocyte Colony-Stimulating Factor 2Everolimus 2Cladribine 2Carboplatin 2Busulfan 2Arsenic Trioxide 2venetoclax 1veliparib 1trebananib 1sargramostim 1romiplostim 1romidepsin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Monocytic, Acute × pegylated granulocyte colony-stimulating factor × Clear all
NCT04196010 2023-12-28

Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms

University of Washington

Phase 1 Terminated
13 enrolled
Other hematologic neoplasm

Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡